DALLAS, July 19, 2018 (GLOBE NEWSWIRE) -- Rocky Mountain

New Post Public Reply Private Reply Replies (2) Message Board
adirondackhi
904
DALLAS, July 19, 2018 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTCQB:RMHB), a fully reporting lifestyle brand management company specializing in high-quality health and wellness products, announced today that Michael Welch, President and Chief Executive Officer of Rocky Mountain High Brands, Inc., was interviewed on Tuesday, July 17, 2018 by two Dallas television stations, CBS11 and CW33, for stories on the tremendous growth of hemp-derived CBD products. The Company also announced that it recently entered into an agreement with Real News PR, a Dallas-based public relations firm owned by former newscaster Jeff Crilley.

In both interviews, Mr. Welch discussed a variety of topics relating to the CBD-infused products the Company markets to consumers.

To view both interviews, please follow the links below:

CBS11 - https://youtu.be/nQGbUdFJOYE

CW33 - https://youtu.be/Q6mcQBPdTNk

Mr. Welch stated, "We are very excited about our new relationship with former newscaster Jeff Crilley and his Real News PR public relations firm. Last week, they scheduled me on In the Know with Brian Glenn on 620 AM KEXB Experts in Business. On Tuesday, they scheduled back to back interviews in our Rocky Mountain High Brands corporate offices with reporters from television stations CBS11 and CW33. Overall, we were pleased with the exposure, however, the CBS11 report contained some inaccurate information that needs further clarification:

-- The reporter named me as the owner of Rocky Mountain High Brands, versus

indicating that it is a publicly traded company.

-- The approximate investment that the Company has made in launching our

hemp-derived CBD brand was implied to be my personal investment versus a

corporate investment.

-- The reporter said that I was unaware of what the Texas law is, which is

an inaccurate statement."

Mr. Welch continued, "The Company made the decision to engage Jeff Crilley and Real News PR after being approached by several public relations firms. In the past, the Company has worked with public relations firms that could not meet our desired goals. By choosing the best public relations firm, we believe that we can increase exposure of the Company, its brands, and its products to consumers, investors, and shareholders."

Mr. Welch concluded, "Rocky Mountain High Brands has a great story to tell as evidenced by the media interest in the nation's fifth largest television market. We believe that Jeff Crilley and his team are the perfect fit to take our consumer awareness campaign to the next level."

About Jeff Crilley:

Jeff Crilley retired from TV news after 25 years in the business to start the country's first "all journalist" PR firm. During his career he made hundreds of national news appearances including CNN, CNN Headline News, FOX News, The Discovery Channel, Good Morning America and The CBS Early Show.

He has been recognized by his peers with dozens of national and regional awards including an Emmy, the National Headliners Award, the Edward R. Murrow Award, the Thurgood Marshall Award, and in 2004 was named by the Texas Associated Press as "The Best TV Reporter in the State."

About Real News PR:

Real News Public Relations is the nation's first all-journalist PR firm, staffed by experienced, award-winning reporters, editors, and producers. After witnessing the failures of the public relations industry from within the news room, Real News PR was founded in 2008 by a team of media experts with the purpose of delivering results instead of promises.

For more information, visit http://www.realnewspr.com/ .

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading